These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Blood level of middle molecular substances during uraemia and haemodialysis. Dzúrik R; Bozek P; Reznícek J; Oborníková A Proc Eur Dial Transplant Assoc; 1973; 10(0):263-70. PubMed ID: 4802412 [No Abstract] [Full Text] [Related]
7. What remains of the "middle molecule" hypothesis today? Brunner H; Mann H Contrib Nephrol; 1985; 44():14-39. PubMed ID: 3886282 [No Abstract] [Full Text] [Related]
8. [Changes in serum profile of medium molecules in patients treated with dialysis for various lengths of time]. Manari A; Buzio C; Calderini C; David S; Montagna G; Quaretti P; Gröf J; Migone L Minerva Nefrol; 1982; 29(2):93-100. PubMed ID: 7133545 [No Abstract] [Full Text] [Related]
9. A defense of the middle molecule hypothesis. Funck-Brentano JL; Cueille GF; Man NK Kidney Int Suppl; 1978 Jun; (8):S31-5. PubMed ID: 278894 [No Abstract] [Full Text] [Related]
10. Gel-filtration on psoriasic and uremic serum and dialysis fluid. Lamperi S; Buoncristiani U; Carozzi S; Cozzari M; Icardi A; Trasforini D Artif Organs; 1981; 4 Suppl():156-9. PubMed ID: 7295083 [TBL] [Abstract][Full Text] [Related]
11. Serum chromatographic pattern in different dialysis strategies. Ringoir S; De Smet R Int J Artif Organs; 1978 Sep; 1(5):218-23. PubMed ID: 689764 [TBL] [Abstract][Full Text] [Related]
12. [An effect of chromatographic fraction ultrafiltrate of plasma on aggregation of blood platelets in patients with chronic uremia]. Popławski A; Myśliwiec M Pol Merkur Lekarski; 1996 Oct; 1(4):246-8. PubMed ID: 9156935 [TBL] [Abstract][Full Text] [Related]
13. Chromatographic analysis of middle molecules in plasma ultrafiltrates of uraemic patients. Popławski A; Myśliwiec M Nephrol Dial Transplant; 1993; 8(2):188. PubMed ID: 8384345 [No Abstract] [Full Text] [Related]
14. Plasma middle molecules in asymptomatic and "sick" uremic patients. Asaba H; Bergström J; Fürst P; Johnson C; Yahiel V Artif Organs; 1981; 4 Suppl():137-42. PubMed ID: 7295080 [TBL] [Abstract][Full Text] [Related]
15. Separation of peptides of "middle" molecular weight from biological fluids of patients with uremia. Fürst P; Bergström J; Gordon A; Johnsson E; Zimmerman L Kidney Int Suppl; 1975 Feb; (3):272-5. PubMed ID: 1057698 [No Abstract] [Full Text] [Related]
16. Inhibition of phagocytosis by a middle molecular fraction from ultrafiltrate. Ringoir SM; van Landschoot N; de Smet R Clin Nephrol; 1980 Mar; 13(3):109-12. PubMed ID: 7379359 [TBL] [Abstract][Full Text] [Related]
17. The road toward the identification of middle molecules. Preliminary Committee Meeting, Avignon, France November 28-29, 1980. Bergstrom J; Funck-Brentano JL; Klinkmann H Artif Organs; 1980 Aug; 4(3):209-10. PubMed ID: 7417037 [No Abstract] [Full Text] [Related]